## Abstract The clinical relevance of hepatitis B virus (HBV) genotypes has been documented; however, the prevalence of mixed HBV genotype infections in at‐risk groups remains controversial. The HBV genotypes were determined in 325 HBV‐infected intravenous drug users (IVDU) who were at a greater ri
High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in North-Eastern Poland
✍ Scribed by S. Chlabicz; R. Flisiak; O. Kowalczuk; A. Wiercińska-Drapalo; B. Pytel-Krolczuk; D. Prokopowicz; L. Chyczewski
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 88 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The aim of this study was to describe the distribution of hepatitis C genotypes among intravenous drug users in north‐eastern Poland. The study group included intravenous drug users recruited at a drug treatment center and a clinic for HIV‐infected patients. HCV infection was confirmed by qualitative nested RT‐PCR to test for the presence of HCV RNA. Genotypes were determined by 5′UTR sequencing and comparing the results with known genotype sequences. Among 111 HCV‐infected and HCV–RNA‐positive intravenous drug users, the most prevalent genotypes were 1 (38.7%), 3 (37.8%), and 4 (23.4%). Most infections with genotype 4 (88.5%) were found among HCV–HIV‐coinfected drug users. The study demonstrated a high prevalence of genotype 4 (23.4%) among HCV‐infected Polish drug users. J. Med. Virol. 80:615–618, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
An RT-PCR assay using primers from the 5Ј-UTR of the GBV-C/HGV genome was used to detect viremia, and a serological assay was used to detect past exposure to GBV-C/HGV, in sera from 106 imprisoned Greek intravenous drug users. High seroprevalence rates indicative of the parenteral route of transmiss
## Abstract The epidemiology and impact of occult HBV infection in intravenous drug users remain largely unknown. The aim of the study was to investigate the prevalence of occult HBV infection among intravenous drug users in Taiwan. Molecular assays were used to determine the level of serum HBV DNA
## Abstract Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In response to this, a population‐based study of 319 consenting adults resident in a remote village of Gabon was undertaken (mean age: 38 years; age range: 13–85+; sex ratio: 0.74). Screening for